Published in Drug Law Weekly, December 25th, 2007
"The contribution of ROS to PE (1x10(-9)-1x10(-5)mol/L)- and ET-1 (1x10(-10)-1x10(-8)mol/L)-induced contractions and the influence of ROS in BK (1x10(-9)-1x10(-5)mol/L) relaxation of PE (1x10(-7)mol/L) or ET-1 (1x10(-9)mol/L)-induced tension was evaluated in the aorta in the presence or absence of the following antioxidants: catalase (CAT, 300 U/mL),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.